Literature DB >> 16391328

Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners.

Joseph Watine1, Bruno Friedberg, Eva Nagy, Rita Onody, Wytze Oosterhuis, Peter S Bunting, Jean-Christophe Charet, Andrea Rita Horvath.   

Abstract

BACKGROUND: It is not clear if good methodologic quality in current practice guidelines necessarily leads to more valid recommendations, i.e., those that are supported with consistent research evidence or, when evidence is conflicting or lacking, with sufficient consensus among the guideline development team. To help clarify this issue, we assessed whether there is a link between methodologic quality and recommendation validity in practice guidelines for the use of laboratory tests in the management of patients with non-small cell lung cancer (NSCLC).
METHODS: We conducted a systematic review of data on laboratory tests in NSCLC published in English or in French within the last 10 years and retrieved 11 practice guidelines for the use of these tests. The guidelines were critically appraised and scored for methodologic quality and recommendation validity based on the Appraisal of Guidelines Research and Evaluation (AGREE) criteria and on the systematic review.
RESULTS: Overall, these 11 guidelines had considerable shortcomings in methodologic quality and, to a lesser extent, in recommendation validity. Practice guidelines with the best methodologic quality were not necessarily the most valid in their recommendations, and conversely.
CONCLUSIONS: Poor methodologic quality and lack of recommendation validity in laboratory medicine call for methodologic standards of guideline development and for international collaboration of guideline development agencies. We advise readers of guidelines to critically evaluate the methods used as well as the content of the recommendations before adopting them for use in practice.

Entities:  

Mesh:

Year:  2006        PMID: 16391328     DOI: 10.1373/clinchem.2005.056952

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  35 in total

Review 1.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

2.  [Evidence-based information concerning increasing age in German guideline portals: comparison using heart failure as an example].

Authors:  B Weiss
Journal:  Z Gerontol Geriatr       Date:  2011-04       Impact factor: 1.281

3.  Rigorous development does not ensure that guidelines are acceptable to a panel of knowledgeable providers.

Authors:  Teryl K Nuckols; Yee-Wei Lim; Barbara O Wynn; Soeren Mattke; Catherine H MacLean; Philip Harber; Robert H Brook; Peggy Wallace; Rena H Garland; Steven Asch
Journal:  J Gen Intern Med       Date:  2007-11-21       Impact factor: 5.128

4.  What sort of evidence do we need in primary care?

Authors:  Sharon Mickan; Deborah Askew
Journal:  BMJ       Date:  2006-03-18

5.  Prostate cancer: How good are guidelines for localized prostate cancer?

Authors:  John Graham
Journal:  Nat Rev Urol       Date:  2015-02-03       Impact factor: 14.432

6.  Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.

Authors:  Annemieke Floor-Schreudering; Peter A G M De Smet; Henk Buurma; Sonia Amini; Marcel L Bouvy
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

7.  Optimizing the language and format of guidelines to improve guideline uptake.

Authors:  Samir Gupta; Navjot Rai; Onil Bhattacharrya; Alice Y Y Cheng; Kim A Connelly; Louis-Philippe Boulet; Alan Kaplan; Melissa C Brouwers; Monika Kastner
Journal:  CMAJ       Date:  2016-04-18       Impact factor: 8.262

8.  Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.

Authors:  B Gagnon; M Abrahamowicz; Y Xiao; M-E Beauchamp; N MacDonald; G Kasymjanova; H Kreisman; D Small
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

Review 9.  Evidence base in guideline generation in diabetes.

Authors:  I Mühlhauser; G Meyer
Journal:  Diabetologia       Date:  2013-03-09       Impact factor: 10.122

Review 10.  The systematic guideline review: method, rationale, and test on chronic heart failure.

Authors:  Christiane Muth; Jochen Gensichen; Martin Beyer; Allen Hutchinson; Ferdinand M Gerlach
Journal:  BMC Health Serv Res       Date:  2009-05-08       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.